News – Page 745 – Endpoints News

Amgen showcases its last big round of promising KRAS G12C data for sotorasib. Next up: A likely marketing campaign ...

5 years ago

Bayer and AskBio expand grand gene therapy ambitions with new Parkinson's program, top scientist

5 years ago

Medigene cuts TCR-T therapy in pivot to focus on solid tumors

5 years ago

GlaxoSmithKline moves malaria vaccine production to India; Nevakar bags European partner and nine-figure deal

5 years ago

Lilly attempts to revive an old idea for tackling pain, licensing PhI program from Japan’s Asahi Kasei Pharma

5 years ago

Thermo Fisher platform seeks to expedite donor cell cultivation for allogeneic cell therapies

5 years ago

One of the most ambitious startup teams in biotech just outlined plans for a $400M IPO and a valuation of about $4B

5 years ago

ARCH announces largest fund yet, raising $1.85B to back mental health, cell and gene editing approaches

5 years ago

Top gene therapy deals, M&A pacts in 2020 highlight another big year in one of the hottest fields in biopharma

5 years ago

Advocacy groups don't want Janet Woodcock to head the FDA, blasting ‘regulatory failures’ in opioid crisis

5 years ago

Dean Li kicks off Merck's post-Roger Perlmutter era by teaming with Artiva and its off-the-shelf CAR-NK tech

5 years ago

Takeda earns win for its TKI inhibitor in tiny lung cancer group — but GI side effects could be an early red flag

5 years ago

Covid-19 roundup: Controversy around colchicine percolates after study failure; AstraZeneca's meeting with EU was ...

5 years ago

'Bank of BARDA': Investigation finds HHS raided pandemic preparedness funds for decade before Covid-19

5 years ago

BeiGene's PD-1 scores PhIII win in esophageal cancer — a 'key indication' tapped by Novartis in $650M deal

5 years ago

CDER lays out 2021 guidance agenda

5 years ago

As new Covid-19 task force gets underway, threat looms of vaccine, monoclonal antibody-resistant variants

5 years ago

Psychedelic biotech ATAI hopes to expand portfolio through research partnership with Mass General

5 years ago

Pfizer's big blockbuster Xeljanz flunks its post-marketing safety study, renewing harsh questions for JAK class

5 years ago

Bomb squad called to AstraZeneca vaccine plant; Lumen nabs CARB-X award for low-cost antidiarrheal

5 years ago

AstraZeneca CEO Pascal Soriot severs an unusual board connection, steering clear of conflicts while retaining ...

5 years ago

Leaps by Bayer backs a protein engineering startup taking on Aimmune — and Nestlé — in peanut allergy

5 years ago

Recall report: Nostrum recalls another lot of metformin as carcinogen concerns continue

5 years ago

Foresite returns to the SPAC well, as investors wonder how long the run can last

5 years ago

First page Previous page 742 743 744745746 747 748 Next page Last page